Skip to content

The Impact of Early Mobilization Protocol in Patients in the ICU

The Impact of Early Mobilization Protocol in Patients in the ICU of the University Hospital of Santa Maria.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01769846
Enrollment
28
Registered
2013-01-17
Start date
2015-03-31
Completion date
2018-08-31
Last updated
2018-10-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Length of Stay, Muscle Thickness of the Quadriceps Femoris, Muscle Weakness, Quality of Life, Weaning Acceleration

Brief summary

Advances in intensive care and mechanical ventilation (MV) in the past two decades have increased critically ill patient survival. However, some patients require prolonged MV (PMV) and are deconditioned due to respiratory insufficiency caused by underlying disease, adverse effects of medications, and prolonged immobilization. Patients in the intensive care unit (ICU) are often confined to their beds, which results in inactivity, immobility, and severe osteomyoarticular system dysfunction. Our hypothesis is that an early mobilization protocol improves muscle thickness (MT) of the quadriceps femoris, peripheral muscle strength, perceived functional status, gait speed, quality of life, duration of mechanical ventilation, ICU length of stay of the critically ill patient. The purpose of this study is to evaluate the effects of implementation an early mobilization protocol in critically ill patients in the Intensive Care Unit of the University Hospital of Santa Maria.

Interventions

Patients in the treatment group additionally received a cycling exercise session 7 days a week, using a bedside cycle ergometer (MOTOmed Letto 2, RECK-Technik GmbH & Co. KG, Betzenweiler, Germany). The device offers the possibility to conduct passive or active cycling at six levels of increasing resistance. The aim of each session was to have the patient cycle for 30 mins at an individually adjusted intensity level. Patients were placed in a comfortable position in between the supine and the semirecumbent position.

Sponsors

Universidade Federal de Santa Maria
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (18 years of age or greater) * Patients in the first 24 hours of mechanical ventilation. * Patients in the deep sedation will be evaluated by the Richmond Agitation-Sedation Scale (score -4). * Hemodynamically stable.

Exclusion criteria

* Rapidly developing neuromuscular disease * Evolution of brain death * Cardiopulmonary arrest * Elevated intracranial pressure * Ruptured/leaking aortic aneurysm * Acute MI before peak troponin has been reached * Absent lower limb * Pregnancy * Unstable fractures contributing to likely immobility * Hospitalization prior to ICU admission \>5 days * Enrollment in another clinical trial

Design outcomes

Primary

MeasureTime frameDescription
Muscle thickness (MT) of the quadriceps femoris.Change from baseline at 14 day of ICU admission, an average of 1 month.MT of the quadriceps femoris will be assessed by ultrasonography (baseline and 14 day).
Muscle thickness (MT) of the diaphragm.Change from baseline at 14 day of ICU admission, an average of 1 month.MT of the diaphragm will be assessed by ultrasonography (baseline and 14 day).

Secondary

MeasureTime frameDescription
Rectus femoris and vastus intermedius thickness.Change from baseline at 14 day of ICU admission, an average of 1 month.Rectus femoris and vastus intermedius thickness will be assessed by ultrasonography (baseline and 14 day).
Muscle strengthFirst day of the patient was cooperative and responsive and at day 14 of ICU admission, an average of 1 month.Muscle strength in arms and legs will be measured by the Medical Research Council (MRC) scale.
Gait speedStudy completion, an average of 2 months (hospital discharge)Gait speed will be measured by the six-meter gait speed test (GST)
Peripheral muscle strength of the lower limbsStudy completion, an average of 2 months (hospital discharge)Peripheral muscle strength of the lower limbs will be measured by 30 second chair stand test
Quality of life following hospital dischargeThree months after hospital discharge SF36Quality of life will be measured by a questionnaire 36-item Short Form Health Survey
Rectus femoris cross-sectional areaChange from baseline at 14 day of ICU admission, an average of 1 month.Rectus femoris cross-sectional area will be assessed by ultrasonography (baseline and 14 day).
ICU length of stayPatients will be followed until ICU discharge, an expected 2 days to 3 weeks.
Weaning AccelerationPatients will be followed until ICU discharge, an expected 2 days to 3 weeks
Side effects of mobilization protocolDuring and 30 minutes after mobilization therapy during ICU stay, approximately 1 to 2 weeks.Haemodynamic response to mobilization. Response in systolic and diastolic blood pressure. Response in heart rate. Response in peripheral oxygen saturation.
Length of hospital stayPatients will be followed until hospital discharge, an expected 4 to 6 weeks
MortalityPatients will be followed until three months after hospital discharge
Vastus intermedius, rectus femoris and diaphragm echo intensity.Change from baseline at 14 day of ICU admission, an average of 1 month.Vastus intermedius, rectus femoris and diaphragm echo intensity will be assessed by ultrasonography (baseline and 14 day)

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 27, 2026